Acute vestibular syndrome associated with anti-GQ1b antibody. 2019

Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
From the Department of Neurology (S.-U.K.), Korea University Medical Center, Seoul; Department of Neurology (J.-Y.C., J.-S.K.), Seoul National University College of Medicine; Research Administration Team (H.-J.K.), Dizziness Center (J.-Y.C., J.-S.K.), Clinical Neuroscience Center, and Department of Neurology (J.-Y.C., J.-S.K.), Seoul National University Bundang Hospital, Seongnam; and Department of Neurology (J.K.K.), Dong-A University College of Medicine, Busan, South Korea.

To delineate the clinical features and ocular motor findings in acute vestibular syndrome (AVS) associated with anti-GQ1b antibodies. We reviewed 90 patients with positive serum anti-GQ1b antibody in association with various neurological syndromes at Seoul National University Bundang Hospital from 2004 to 2018. The diagnoses included typical Miller Fisher syndrome (n = 31), acute ophthalmoplegia without ataxia (n = 27), Guillain-Barre syndrome with ophthalmoplegia (n = 18), AVS (n = 11), and Bickerstaff brainstem encephalitis (n = 3). Of them, the 11 patients with AVS formed the basis of this study. We also conducted a systematic review on AVS reported in association with anti-GQ1b antibody. Patients with AVS showed various ocular motor findings that included head-shaking nystagmus (n = 6), spontaneous nystagmus (n = 5), gaze-evoked nystagmus (n = 5), central positional nystagmus (n = 3), canal paresis (n = 2), and abnormal head-impulse tests (n = 1) without any internal or external ophthalmoplegia. Compared to those with other subtypes, patients with AVS mostly showed normal deep tendon reflexes (8 of 11 [73%], p = 0.002) and normal results on nerve conduction studies (4 of 4 [100%], p = 0.010). The clinical and laboratory findings resolved or improved markedly in all patients within 6 months of symptom onset. Systematic review further identified 7 patients with AVS and positive serum anti-GQ1b antibody who showed various ocular motor findings, including gaze-evoked nystagmus, saccadic dysmetria, central positional nystagmus, and ocular flutter or opsoclonus. Anti-GQ1b antibody may cause acute vestibulopathy by involving either the central or peripheral vestibular structures. AVS may constitute a subtype of anti-GQ1b antibody syndrome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
April 2010, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
March 1995, Journal of neurology,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
August 2004, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
April 2021, Journal of clinical neurology (Seoul, Korea),
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
March 1998, American journal of ophthalmology,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
May 1996, Annals of neurology,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
November 1994, Nihon rinsho. Japanese journal of clinical medicine,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
January 2022, Neurology India,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
January 2001, Ophthalmology,
Sun-Uk Lee, and Hyo-Jung Kim, and Jeong-Yoon Choi, and Jong Kuk Kim, and Ji-Soo Kim
August 2016, Infection,
Copied contents to your clipboard!